  | Chabannon, C., Benakli, M., Alexandrova, K., Coze, C., Dalle, J.-H., Giraud, C., Huynh, P., Kanouni, T., Kanold, J., Lesieur, I., Levavasseur, A., Yakoub-Agha, I., & Baudoux, E. (2024). Cytaphérèses pédiatriques (atelier SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2023.12.008  Peer Reviewed verified by ORBi |
  | Delgadillo, J., Kerkelä, E., Waters, A., van den Akker, E., LECHANTEUR, C., BAUDOUX, E., Gardiner, N., De Vos, J., & Vives, J. (2023). A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe. Cytotherapy. doi:10.1016/j.jcyt.2023.08.001 Peer Reviewed verified by ORBi |
 | Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464 Peer Reviewed verified by ORBi |
 | Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192 Peer Reviewed verified by ORBi |
 | GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 Peer Reviewed verified by ORBi |
 | Forcade, E., Bacquet, S., Ballot, C., Capin, L., GARNIER, F., Giraud, C., Guérout-Vérité, M.-A., Letellier, C., MAGNANI, A., MAMEZ, A.-C., NASONE, J., Sinayoko, M., BAUDOUX, E., MIALOU, V., Yakoub-Agha, I., & Calmels, B. (2022). Modalités et impact de la cryopréservation des greffons allogéniques en contexte pandémique : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2022.03.015 Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320 Peer Reviewed verified by ORBi |
 | Jöris, M., Paulson, K., Foley, L., Duffy, M., Querol, S., Gomez, S., & BAUDOUX, E. (2021). Worldwide survey on key indicators for public cord blood banking technologies: By the World Marrow DonorAssociation Cord Blood Working Group. Stem Cells Translational Medicine, 10, 222-229. doi:10.1002/sctm.20-0246 Peer Reviewed verified by ORBi |
 | Ingels, J., De Smet, S., Heyns, K., Lootens, N., Segaert, J., Taghon, T., Leclercq, G., Vermaelen, K., WILLEMS, E., BAUDOUX, E., Kerre, T., Baron, F., & Vandekerckhove, B. (2021). Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor-derived CMV-specific T cells. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, 76, 482-486. doi:10.1080/17843286.2020.1752446 Peer reviewed |
 | Calmels, B., Gautier, E., Magnani, A., Magrin, E., Mamez, A. C., Vaissié, A., Yakoub-Agha, I., & BAUDOUX, E. (2020). Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2020.06.005 Peer Reviewed verified by ORBi |
 | Dalle, J.-H., BAUDOUX, E., Caillat-Zucman, S., Colledani, F., PEREIRA-MARTINS, M., Bruno, B., Nguyen, S., Robin, M., & Rubio, M. T. (April 2020). Le développement des cellules CAR-T et autre thérapie génique : tout n’est pas si simple [letter to the editor]. Bulletin du Cancer, 107 (4), 408-409. doi:10.1016/j.bulcan.2020.03.002 Peer Reviewed verified by ORBi |
 | HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315. Peer Reviewed verified by ORBi |
 | De Vos, J., BAUDOUX, E., Bay, J.-O., Calmels, B., Cras, A., El Cheikh, J., Guerout-Verite, M.-A., Lacassagne, M.-N., Lamure, S., Letellier, C., Menard, A.-L., Daguindau, E., Poiré, X., Yakoub-Agha, I., & Guillaume, T. (December 2019). Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 106, 35-S39. doi:10.1016/j.bulcan.2018.10.002 Peer Reviewed verified by ORBi |
 | ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046 Peer Reviewed verified by ORBi |
 | de Jamblinne, Y., BAUDOUX, E., Delo, C., & Coppieters, Y. (August 2018). Influence de facteurs obstétricaux sur les caractéristiques des greffons de sang de cordon ombilical. Gynécologie Obstétrique et Fertilité, 46, 639-644. doi:10.1016/j.gofs.2018.07.005 Peer Reviewed verified by ORBi |
 | HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8 Peer Reviewed verified by ORBi |
 | Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020 Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001 Peer Reviewed verified by ORBi |
 | GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864 Peer Reviewed verified by ORBi |
 | Nikolajeva, O., Rocha, V., Danby, R., Ruggeri, A., Volt, F., BAUDOUX, E., Gomez, S. G., Kögler, G., Larghero, J., Lecchi, L., Sanchez Martinez, M., Navarrete, C., Pouthier, F., Querol, S., Kenzey, C., Szydlo, R., Gluckman, E., & Madrigal, A. (2017). Umbilical Cord Blood Cytomegalovirus Serostatus Does Not Have an Impact on Outcomes of Umbilical Cord Blood Transplantation for Acute Leukemia. Biology of Blood and Marrow Transplantation. doi:10.1016/j.bbmt.2017.06.022 Peer Reviewed verified by ORBi |
 | Boulanger, F., Decot, V., Bulliard, G., Calmels, B., Giraud, C., Lacassagne, M. N., Magnani, A., Pouthier, F., Thibert, J. B., Tirefort, Y., Yakoub-Agha, I., & BAUDOUX, E. (2016). Modalités de préparation, cryopréservation, décongélation des cellules souches hématopoïétiques et précautions pour infusion au patient: recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. doi:10.1016/j.bulcan.2016.09.002 Peer Reviewed verified by ORBi |
 | Saccardi, R., Tucunduva, L., Ruggeri, A., Ionescu, I., Koegler, G., Querol, S., Grazzini, G., Lecchi, L., Nanni Costa, A., Navarrete, C., Pouthier, F., Larghero, J., Regan, D., Freeman, T., Bittencourt, H., Kenzey, C., Labopin, M., BAUDOUX, E., Rocha, V., & Gluckman, E. (31 May 2016). Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis. Transfusion, 56 (8), 2021-2029. doi:10.1111/trf.13661 Peer Reviewed verified by ORBi |
 | SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235. Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y Peer Reviewed verified by ORBi |
 | Rouard, H., Boulanger, F., BAUDOUX, E., Calmels, B., de Vos, J., Gautier, E., Lacassagne, M. N., Tirefort, Y., Turlure, P., Chabannon, C., GERARD, C., GIET, O., Letellier, C., MONFORT, M., Thibert, J.-B., & Yakoub-Agha, I. (December 2015). Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC. Hématologie, 21 (Supp 3), 42-46. doi:10.1684/hma.2015.1070 Peer reviewed |
 | Pirnay, J. P., BAUDOUX, E., Cornu, O., Delforge, A., Delloye, C., Guns, J., Heinen, E., Van den Abbeel, E., Vanderkelen, A., Van Geyt, C., van Riet, I., Verbeken, G., De Sutter, P., Verlinden, M., Huys, I., Cockbain, J., Chabannon, C., Dierickx, K., Schotsmans, P., ... Sterckx, S. (07 April 2015). Access to human tissues for research and product development. EMBO Reports, 16 (5), 1-6. doi:10.15252/embr.201540070 Peer Reviewed verified by ORBi |
 | Saccardi, R., Azqueta, C., Ballerini, C., Ballerini, L., BAUDOUX, E., Caporale, R., Dal Pozzo, S., Gomez, S., Kogler, G., Lanza, F., Angelotti, M., Madrigal, A., Ongari, M., Querol, S., Radke, T., Rocha, V., Ruggeri, A., Urbani, S., & Gluckman, E. (2015). Modification of standard ISHAGE methodology for CD34+ cells count on thawed Cord Blood Units: results from a multi-center Eurocord/Netcord study. Bone Marrow Transplantation, 50, 562. Peer Reviewed verified by ORBi |
 | Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394 Peer Reviewed verified by ORBi |
 | Binsfeld, M., HANNON, M., Otjacques, E., Humblet-Baron, S., BAUDOUX, E., BEGUIN, Y., BARON, F., & CAERS, J. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology, Immunotherapy, 64, 989-998. doi:10.1007/s00262-015-1708-2 Peer Reviewed verified by ORBi |
 | SACCARDI, R., AZQUETA, C., BALLERINI, L., BAUDOUX, E., DAL POZZO, S., GOMEZ, S., KOGLER, G., LANZA, F., ONGARI, M., QUEROL, S., FALK RADKE, T., ROCHA, V., RUGGERI, A., URBANI, S., & GLUCKMAN, E. (06 December 2014). Flow Cytometry Assessment of CD34+ Viability in Thawed Cord Blood Units: A Multi-Center Eurocord and Netcord Study. Blood, 124. Peer Reviewed verified by ORBi |
 | DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56. Peer reviewed |
 | RUGGERI, A., LABOPIN, M., SORMANI, M. P., SANZ, G., SANZ, J., VOLT, F., MICHEL, G., LOCATELLI, F., DIAZ DE HEREDIA, C., O’BRIEN, T., ARCESE, W., IORI, A. P., QUEROL, S., KOGLER, G., LECCHI, L., POUTHIER, F., GARNIER, F., NAVARRETE, C., BAUDOUX, E., ... SACCARDI, R. (September 2014). Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. Haematologica, 99, 1509-1515. doi:10.3324/haematol.2014.109280 Peer Reviewed verified by ORBi |
 | CALMELS, Boulanger, F., BAUDOUX, E., Decot, V., Fawaz, A., Giraud, C., Hivert, B., Garderet, L., Milpied, N., & Yakoub-Agha. (01 July 2014). Modalités de conservation et de destruction des produits cellulaires cryopréservés : recommandations de la SFGM-TC. Pathologie Biologie, 62 (3). doi:10.1016/j.patbio.2014.05.006 Peer Reviewed verified by ORBi |
 | De Vos, J., Birebent, B., Faucher, C., GIET, O., Hicheri, Y., Lemarie, C., BAUDOUX, E., Garnier, F., Larghero, J., Pouthier, F., Thibert, J., & Yakoub-Agha, I. (2014). Contrôle de qualité des USP via segments attachés : recommandations de la SFGM-TC. Pathologie Biologie. doi:10.1016/j.patbio.2014.05.005 Peer Reviewed verified by ORBi |
 | Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279 Peer Reviewed verified by ORBi |
 | Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9 Peer Reviewed verified by ORBi |
 | MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068 Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222 Peer Reviewed verified by ORBi |
 | Klykens, J., Pirnay, J., Verbeken, G., GIET, O., BAUDOUX, E., Jashari, R., Vanderkelen, A., & Ectors, N. (2013). Cleanrooms and tissue banking how happy I could be with either GMP or GTP? Cell and Tissue Banking. doi:10.1007/s10561-012-9355-8 Peer Reviewed verified by ORBi |
 | Rocha, V., Spellman, S., Zhang, M., Ruggeri, A., Purtill, D., Brady, C., Baxter-Lowe, L., BAUDOUX, E., Bergamaschi, P., Chow, R., Freed, B., Koegler, G., Kurtzberg, J., Larghero, J., Lecchi, L., Nagler, A., Navarette, C., Prasad, V., Pouthier, F., ... Eapen, M. (2012). Effect of HLA-matching recipients to donor non-inherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation. Peer Reviewed verified by ORBi |
 | PIRNAY, J., ECTORS, N., DELLOYE, C., DUFRANE, D., BAUDOUX, E., VAN BRUSSEL, M., CASAER, M., DE VOS, D., DRAYE, J., ROSE, T., JENNES, S., NEIRINCKX, P., LAIRE, G., ZIZI, M., & VERBEKEN, G. (2012). Beware of the commercialization of human cells and tissues: situation in the European Union. Cell and Tissue Banking. doi:10.1007/s10561-012-9323-3 Peer Reviewed verified by ORBi |
 | GLUCKMAN, E., ROCHA, V., BAUDOUX, E., BOO, M., KURTZBERG, J., WELTE, K., NAVARRETE, C., & VAN WALRAVEN, S. (12 July 2011). Family-directed umbilical cord blood banking. Haematologica, 96 (11), 1700-17007. doi:10.3324/haematol.2011.047050 Peer Reviewed verified by ORBi |
 | Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011 Peer Reviewed verified by ORBi |
 | Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x Peer Reviewed verified by ORBi |
 | Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x Peer Reviewed verified by ORBi |
 | Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8. Peer Reviewed verified by ORBi |
 | Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80. Peer Reviewed verified by ORBi |
 | Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220 Peer Reviewed verified by ORBi |
 | Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7 Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7. Peer Reviewed verified by ORBi |
 | Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6 Peer reviewed |
 | Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x Peer Reviewed verified by ORBi |
 | Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484 Peer Reviewed verified by ORBi |
 | Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88. Peer Reviewed verified by ORBi |
 | Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173 Peer Reviewed verified by ORBi |
 | Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18. Peer Reviewed verified by ORBi |
 | Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x Peer Reviewed verified by ORBi |
 | Baudoux, E., Blaffart, F., Bouffioux, C., Caprasse, M., Courtois, F., Cremasco, M.-R., De Pasqual, E., Fassotte, M.-F., Gillet, P., Lamy, M., Larbuisson, R., Lemaire, R., Merciny, M., Moutschen, M., Radermecker, M., Remy, B., & Sondag, D. (2000). La commission d'hemovigilance du CHU. Revue Médicale de Liège, 55 (9), 878-80. Peer reviewed |
 | Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9. Peer Reviewed verified by ORBi |
 | Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x Peer Reviewed verified by ORBi |
 | Baudoux, E., Margraff, U., Coenen, A., Jacobs, X., Deboutez, M., Lungu, C., & Sondag-Thull, D. (1998). Hemovigilance: Clinical Tolerance of Solvent-Detergent Treated Plasma. Vox Sanguinis, 74 (Suppl 1), 237-9. doi:10.1111/j.1423-0410.1998.tb05479.x Peer Reviewed verified by ORBi |
Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x Peer Reviewed verified by ORBi |
Jacquet, M., LAMBERT, V., BAUDOUX, E., Muller, M., Kremers, P., & Gielen, J. (April 1996). Correlation between P450 CYP1A1 Indelibility, MsPI Genotype and Lung Cancer Incidence. European Journal of Cancer, 32A (10), 1701-1706. Peer Reviewed verified by ORBi |
 | Rafii, H., Kenzey, C., Volt, F., Sanz, J., Michel, G., Dalle, J. H., Kleinschmidt, K., BAUDOUX, E., QUEROL, S., Ruggeri, A., Chabannon, C., & Gluckman, E. (11 December 2020). Optimizing Outcomes of Acute Leukemia After Transplants with Single Unrelated Cord Blood Units Selected According to Current International Recommendations for Cell Dose and HLA Match. Bone Marrow Transplantation, 55 (4), 170-171. Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12. Peer Reviewed verified by ORBi |
 | HAUZEUR, J.-P., Tungouz, M., LECHANTEUR, C., Beguin, Y., BAUDOUX, E., de maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., & Gangji, V. (October 2016). Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée. Revue de Chirurgie Orthopédique et Traumatologie, 102, 73. doi:10.1016/j.rcot.2016.08.002 Peer reviewed |
 | WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6. Peer Reviewed verified by ORBi |
 | WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278. Peer Reviewed verified by ORBi |
 | WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3). Peer Reviewed verified by ORBi |
BAUDOUX, E. (2013). Cord blood banking Introduction-State of the art. In E. Gluckman & Cavazzana (Eds.), World Cord blood congress IV and innovative therapies for sickle cell disease. |
 | SACCARDI, R., Tucunduva, L., Ruggeri, A., Ionescu, I., Koegler, G., Querol, S., Lecchi, L., Pouthier, F., Bittencourt, H., Kenzey, C., Gluckman, E., Labopin, M., BAUDOUX, E., & Rocha, V. (01 April 2013). Effect of volume reduction of cord blood units before storage on transplantation outcomes: a retrospective analysis of Eurocord-EBMT and Netcord. Bone Marrow Transplantation, 48, 34. Peer Reviewed verified by ORBi |
 | WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075). Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (October 2021). Local Mesenchymal Stem Cells injection in Crohn’s disease strictures: a phase I-II, open-label clinical study [Poster presentation]. United European Gastroenterology. Peer reviewed |
 | WEEKERS, L., ERPICUM, P., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (16 March 2017). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium. |
 | BAUDOUX, E. (16 November 2016). Sang de cordon état des lieux et perspectives [Paper presentation]. Congrès commun SFGM-TC 16e CONGRES et de la SFBCT 8e CONGRES, Liège, Belgium. |
 | Erpicum, P., WEEKERS, L., DETRY, O., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (28 April 2016). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium. |
 | Grégoire, C., Beguin, Y., Hannon, M., DUBOIS, S., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., Ehx, G., & Baron, F. (29 January 2016). Umbilical cord mesenchymal stromal cells are superior to bone marrow and adipose tissue-derived mesenchymal stromal cells for the treatment of xenogeneic graft-versus-host disease in mice [Poster presentation]. 31th General Meeting of the Belgian Hematological Society. |
 | BAUDOUX, E., Lefebvre, C., & FASTH, A. (16 May 2014). CORD DONOR Safety [Paper presentation]. International Donor Registry Conference 2014, London, United Kingdom. |
 | DETRY, O., DELBOUILLE, M.-H., LECHANTEUR, C., SOMJA, J., DE ROOVER, A., WEEKERS, L., SQUIFFLET, J.-P., Honoré, P., DELVENNE, P., MEURISSE, M., BAUDOUX, E., & BEGUIN, Y. (30 May 2013). INFUSION OF THIRD-PARTY MESENCHYMAL STEM CELLS (MSC) AFTER KIDNEY AND LIVER TRANSPLANTATION: A PHASE I-II, OPEN-LABEL, CLINICAL STUDY (EudraCT 2011-001822-81 & NCT01429038) [Poster presentation]. 13eme rencontre de Beaune, Beaune, France. |
 | DETRY, O., DELBOUILLE, M.-H., LECHANTEUR, C., SOMJA, J., DE ROOVER, A., WEEKERS, L., DELVENNE, P., BAUDOUX, E., & BEGUIN, Y. (19 October 2012). Infusion of third party mesenchymal stem cells (MSC) after kidney and liver transplantation: a phase I-II, open-label, clinical study [Paper presentation]. 4th Expert meeting, Barcelona, Spain. |
 | Baron, F., WILLEMS, E., LECHANTEUR, C., BAUDOUX, E., Frere, P., Vanbellinghen, J., Bruck, F., Gothot, A., HAFRAOUI, K., Fillet, G., & Beguin, Y. (2009). Co-transplantation of mesenchymal stem cells might mitigate acute GvHD without abrogating graftversus- tumour alloreactivity after allogeneic transplantation with non-myeloablative conditioning [Paper presentation]. 35th EBMT Annual Meeting. |
 | WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2006). Nonmyeloablative stem cell transplantation with CD8-depleted or unmalipulated peripheral blood stem cells: a prospective randomized trial [Paper presentation]. 21st General Meeting of the Belgian Hematological Society. |
 | GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc. Peer reviewed |
 | GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc. Peer reviewed |
Van Beckhoven, J., BAUDOUX, E., Duffy, M., Elmoazzen, H., Elwood, N., Gluckman, E., Gomez, S., Korhonen, M., Maeck, J., Querol, S., Ruggeri, A., & Torrabadella, M. (2013). Cord Blood Banking: Cord blood management and evaluation: International networking. In W. Hwang, M. Boo, ... T. Bart (Eds.), A gift for life, WMDA handbook for blood stem cell donation (pp. 178-180). WMDA. |
 | Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217). |
BAUDOUX, E., BEGUIN, Y., Benoit, Y., Billiet, J., Delforge, A., DEVOS, T., Latinne, D., Noens, L., Selleslag, D., Van Riet, I., VANDEKERCKHOVE, B., Vermylen, C., & Zachée, P. (2012). Cord blood for allogeneic use: Clinical and scientific aspects? (8784). Bruxelles, Belgium: Conseil Supérieur de la Santé. |
Angenon, E., BAUDOUX, E., BEGUIN, Y., benoit, Y., Billiet, J., Delforge, A., Devos, T., Ferrant, A., KÖGLER, G., Latinne, D., Faucher, C., NAVARRETE, C., Noens, L., SELLESLAG, D., STRAETMANS, N., VAN RIET, I., & Zachée, P. (2011). Autologous cord blood use: Clinical and scientific aspects. (8677). |
 | BAUDOUX, E., GIET, O., Jöris, M., Byam, C., Rocha, V., Ionescu, I., & Elmoazzen, H. (2016). Importing and Exporting Cord Blood Units. (Foundation for the Accreditation of Cellular Therapies). |
BAUDOUX, E. (2012). Donor and stem cell source selection. (Belgian Hematological Society, Donor and stem cell source selection). |
 | GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211. Editorial Reviewed verified by ORBi |
Baudoux, E. (April 1996). Autologous Blood Donation Plus Epoetin Alfa in Nonanemic Orthopedic Surgery Patients. Seminars in Hematology, 33 (2 Suppl 2), 31-2, discussion 33. |
